• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组蜱抗凝肽对Xa因子的抑制动力学:缓慢紧密结合的抑制机制需要活性位点和外位点相互作用。

Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism.

作者信息

Rezaie Alireza R

机构信息

Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri 63104, USA.

出版信息

Biochemistry. 2004 Mar 30;43(12):3368-75. doi: 10.1021/bi036177y.

DOI:10.1021/bi036177y
PMID:15035608
Abstract

Recombinant tick anticoagulant peptide (rTAP) is a competitive slow- and tight-binding inhibitor of factor Xa (FXa) with a reported equilibrium dissociation constant (K(I)) of approximately 0.2 nM. The inhibitory characteristics and the high selectivity of rTAP for FXa are believed to arise from the ability of the inhibitor to specifically interact with the residues of both the active site as well as those remote from the active site pocket of the protease. To localize the rTAP-interactive sites on FXa, the kinetics of inhibition of wild-type and 18 different mutants of recombinant FXa by the inhibitor were studied by either a discontinuous assay method employing the tight-binding quadratic equation or a continuous assay method employing the slow-binding kinetic approach. It was discovered that K(I) values for the interaction of rTAP with four FXa mutants (Tyr(99) --> Thr, Phe(174) --> Asn, Arg(143) --> Ala, and a Na(+)-binding loop mutant in which residues 220-225 of FXa were replaced with the corresponding residues of thrombin) were elevated by 2-3 orders of magnitude for each mutant. Further studies revealed that the characteristic slow type of inhibition by rTAP was also eliminated for the mutants. These findings suggest that the interaction of rTAP with the P2-binding pocket, the autolysis loop, and the Na(+)-binding loop is primarily responsible for its high specificity of FXa inhibition by a slow- and tight-binding mechanism.

摘要

重组蜱抗凝血肽(rTAP)是一种对凝血因子Xa(FXa)具有竞争性、缓慢且紧密结合的抑制剂,其报道的平衡解离常数(K(I))约为0.2 nM。rTAP对FXa的抑制特性和高选择性被认为源于该抑制剂能够与蛋白酶活性位点以及远离活性位点口袋的残基特异性相互作用的能力。为了定位FXa上与rTAP相互作用的位点,通过采用紧密结合二次方程的间断测定法或采用缓慢结合动力学方法的连续测定法,研究了该抑制剂对野生型和18种不同重组FXa突变体的抑制动力学。结果发现,rTAP与四种FXa突变体(Tyr(99) --> Thr、Phe(174) --> Asn、Arg(143) --> Ala以及一种将FXa的220 - 225位残基替换为凝血酶相应残基的Na(+)结合环突变体)相互作用的K(I)值,每个突变体均升高了2 - 3个数量级。进一步研究表明,这些突变体也消除了rTAP特有的缓慢抑制类型。这些发现表明,rTAP与P2结合口袋、自溶环和Na(+)结合环的相互作用主要是其通过缓慢且紧密结合机制对FXa具有高特异性抑制作用的原因。

相似文献

1
Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism.重组蜱抗凝肽对Xa因子的抑制动力学:缓慢紧密结合的抑制机制需要活性位点和外位点相互作用。
Biochemistry. 2004 Mar 30;43(12):3368-75. doi: 10.1021/bi036177y.
2
Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.旨在了解凝血因子Xa与天然抗凝血酶及肝素激活的抗凝血酶反应性差异机制的诱变研究。
Biochemistry. 2004 Mar 16;43(10):2898-905. doi: 10.1021/bi036145a.
3
Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.凝血酶原酶复合物的选择性抑制:因子Va改变了因子Xa对一种蜱抗凝肽突变体的大分子识别。
Biochemistry. 1997 Jan 7;36(1):181-91. doi: 10.1021/bi962060g.
4
Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.采用基于配体和基于结构的联合方法,剖析代表性因子 Xa 和凝血酶抑制剂的选择性结构决定因素。
J Chem Inf Model. 2011 Aug 22;51(8):1966-85. doi: 10.1021/ci200185q. Epub 2011 Aug 1.
5
Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa.蜱抗凝肽与牛凝血因子Xa复合的意外结合模式。
J Mol Biol. 1998;283(1):147-54. doi: 10.1006/jmbi.1998.2069.
6
Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum.人凝血因子Xa的活性位点和外位点抑制:犬钩口线虫的一种强效线虫抗凝血蛋白NAP5抑制的去γ-羧基凝血因子Xa的结构
J Mol Biol. 2007 Aug 17;371(3):774-86. doi: 10.1016/j.jmb.2007.05.042. Epub 2007 May 18.
7
Tick anticoagulant peptide: kinetic analysis of the recombinant inhibitor with blood coagulation factor Xa.蜱抗凝肽:重组抑制剂与凝血因子Xa的动力学分析
Biochemistry. 1990 Dec 18;29(50):11095-100. doi: 10.1021/bi00502a012.
8
Approaches to selective peptidic inhibitors of factor Xa.凝血因子Xa选择性肽类抑制剂的研究方法。
Chem Biol Drug Des. 2006 Jul;68(1):11-9. doi: 10.1111/j.1747-0285.2006.00404.x.
9
Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa.锡兰钩虫抗凝肽-1:预测的活性位点氨基酸在介导对凝血因子Xa和VIIa抑制中的作用。
Mol Biochem Parasitol. 2004 Sep;137(1):151-9. doi: 10.1016/j.molbiopara.2004.05.011.
10
Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.鉴定与蛋白Z依赖性蛋白酶抑制剂相互作用至关重要的凝血因子Xa残基:抑制作用需要活性位点和外位点相互作用。
J Biol Chem. 2005 Sep 23;280(38):32722-8. doi: 10.1074/jbc.M505517200. Epub 2005 Aug 3.

引用本文的文献

1
De novo assembly of sialotranscriptome of Hyalomma anatolicum and insights into expression dynamics in response to Theileria annulata infection.硬蜱唾液转录组从头组装及对环形泰勒虫感染表达动态的研究。
Exp Appl Acarol. 2024 Dec;93(4):887-906. doi: 10.1007/s10493-024-00962-z. Epub 2024 Sep 13.
2
A Kunitz-type inhibitor from tick salivary glands: A promising novel antitumor drug candidate.一种来自蜱唾液腺的Kunitz型抑制剂:一种有前景的新型抗肿瘤药物候选物。
Front Mol Biosci. 2022 Aug 16;9:936107. doi: 10.3389/fmolb.2022.936107. eCollection 2022.
3
Molecular basis of the clotting defect in a bleeding patient missing the Asp-185 codon in the factor X gene.
一名凝血因子X基因中缺少天冬氨酸-185密码子的出血患者凝血缺陷的分子基础。
Thromb Res. 2014 Nov;134(5):1103-9. doi: 10.1016/j.thromres.2014.08.004. Epub 2014 Aug 20.
4
Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor.蛋白酶原 2 和碱性胰蛋白酶抑制剂抑制因子 XIa 和胰蛋白酶的机制和特异性。
J Biochem. 2010 Oct;148(4):467-79. doi: 10.1093/jb/mvq080. Epub 2010 Jul 20.
5
Salivating for knowledge: potential pharmacological agents in tick saliva.对知识垂涎欲滴:蜱唾液中的潜在药理活性剂
PLoS Med. 2008 Feb;5(2):e43. doi: 10.1371/journal.pmed.0050043.
6
The mechanism of inhibition of antibody-based inhibitors of membrane-type serine protease 1 (MT-SP1).基于抗体的膜型丝氨酸蛋白酶1(MT-SP1)抑制剂的抑制机制。
J Mol Biol. 2007 Jun 15;369(4):1041-51. doi: 10.1016/j.jmb.2007.03.078. Epub 2007 Apr 4.
7
Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.鉴定与蛋白Z依赖性蛋白酶抑制剂相互作用至关重要的凝血因子Xa残基:抑制作用需要活性位点和外位点相互作用。
J Biol Chem. 2005 Sep 23;280(38):32722-8. doi: 10.1074/jbc.M505517200. Epub 2005 Aug 3.